Related Experiment Video
Updated: Sep 16, 2025

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
An International Multicenter Study of Native and Immigrant South Asian Crohn's Disease
Maryam K Ibrahim1, Rebecca Cohen1, Tarun Chhibba2
1Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts.
Background & Aims:
Crohn's disease (CD) has emerged as a global disease, with the fastest rise in incidence in Asia. The impact of immigration (reflecting early-life exposure to one environment and later life to another) on disease phenotype, behavior, and seropositivity has not been examined previously.
Methods:
We phenotyped a cohort of U.S.-residing (immigrant) South Asian patients with CD (SA-CD) and control subjects from 3 U.S. hospitals compared with native SA-CD and control subjects from India and Singapore. These cohorts were compared with a prospective cohort of 1679 U.S.-born White patients with CD (White-CD). Detailed disease phenotype, treatment, acculturation, environmental exposures, and serologies were ascertained.
Results:
Our study consisted of 260 immigrant SA-CD and control subjects, 198 native SA-CD and control subjects, and 1679 White-CD. Both native (59%; P = .02) and immigrant (55%; P = .15) SA-CD demonstrated male predominance compared with White-CD (49%). The mean age at diagnosis for second-generation immigrants (17.7 years) was significantly lower than first-generation immigrants (34 years), native SA-CD (31.7 years) and White-CD (27.7 years); the age at diagnosis was also younger in Western/bicultural-identifying compared with Asian-identifying immigrants (P < .05). Second-generation patients with CD were more likely to have B1 disease compared with native and first-generation SA-CD (odds ratio, 3.48; P = .007). Immigrant patients with CD had higher frequency of perianal involvement compared with native SA-CD and White-CD. However, native-SA-CD more commonly had stricturing disease. The immigrant SA-CD cohort had higher CBir1 flagellin antibody (49%) and anti-outer membrane porin C antibody (19%) positivity rates than anti-Saccharomyces cerevisiae antibody (13%).
Conclusions:
Our international, multicenter study identified both commonalities as well as unique differences in disease phenotype, behavior, serological patterns, and environmental factors by geography and immigrant status. We highlight the importance of changing environment on CD phenotypic expression.
More Related Videos
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
08:27Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF